Approval · Notice of Compliance 26257 · 2021
VIRAZOLE: Notice of Compliance 26257
Issued July 14, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 26257
- Date
- July 14, 2021
- Company
- Bausch Health, Canada Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- The addition of an alternate drug substance manufacturing site. The addition of a release testing site
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VIRAZOLE | Not yet assigned | — |
Medicinal ingredients
- RIBAVIRIN 6 G per VIAL